Gyn-Onc
Advertisement
Women with deep infiltrating endometriosis and/or ovarian endometriosis had the highest risk for ovarian cancer.
Learn how a team implemented pre-screening and fast-track strategies to increase clinical trial enrollment in these patients.
New research highlights the importance of using appropriate patient-reported outcome measures for these patients.
The phase III, placebo-controlled AtTEnd trial included 551 patients, with 23% in each arm having dMMR tumors.
Symptom-triggered testing resulted in 1 in 4 women being diagnosed with high-grade serous ovarian cancer at an early stage.
Researchers identified 6 risk factors for urinary retention that are critical for nurses to be aware of in these patients.
A team of researchers evaluated the Neuman model of care in the perioperative setting for patients with endometrial cancer.
A long-term study points to the importance of evaluating risks and benefits with estrogen versus progesterone with estrogen.
Patients receiving the antibody-drug conjugate showed a 30% reduction in the risk of death compared with chemotherapy.
A new study is shedding light on post-treatment experiences, with many saying they felt they were "left to themselves."
Learn about the link between muscle quality and the risk of postoperative complications in these patients.
Learn how the BOLSTER nurse-led telehealth intervention can help patients with gynecologic cancers manage this condition.
An interim analysis of part 2 of the RUBY trial showed that dostarlimab plus chemotherapy lowered the risk of death by 31%.
Learn how medical history, perceived physician-patient communication, and perceived social support impact patients.
Approximately half of patients with gynecologic malignancies experience financial toxicity.
The expanded approval is based upon results from part 1 of the phase III RUBY trial.
Oncology nurses play a pivotal role in educating patients about these treatment options and ensuring informed decisions.
The conversion to full approval is based on data from the confirmatory MIRASOL trial.
Learn how oncology nurses can be leaders in building oncofertility conversations and programs.
January is Cervical Cancer Awareness Month, which makes it an ideal time to discuss prevention and screening with patients.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.